The prognostic effect of DDX3 upregulation in distant breast cancer metastases

Clinical and Experimental Metastasis

Volumn 34, Issue 1, 2017, Pages 85-92

  Heerma van Voss, Marise R ^a,b   Schrijver, Willemijne A M E ^a   ter Hoeve, Natalie D ^a   Hoefnagel, Laurien D ^a   Manson, Quirine F ^a   van der Wall, Elsken ^a,b   Raman, Venu ^a,b   van Diest, Paul J ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain metastasis; Breast cancer; DDX3; DDX3X; DEAD box RNA helicases; Metastasis

Indexed keywords

DEAD BOX PROTEIN; DEAD BOX RNA HELICASE 3; UNCLASSIFIED DRUG; DDX3X PROTEIN, HUMAN;

ARTICLE; BRAIN DAMAGE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT BREAST CANCER METASTASIS; DISTANT METASTASIS; ENZYME INDUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; METASTATIC BREAST CANCER; MITOSIS RATE; OVERALL SURVIVAL; TRIPLE NEGATIVE BREAST CANCER; BIOSYNTHESIS; BRAIN TUMOR; DISEASE FREE SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; METASTASIS; PATHOLOGY; PROGNOSIS; SECONDARY;

BRAIN NEOPLASMS; DEAD-BOX RNA HELICASES; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM METASTASIS; PROGNOSIS; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 85006741571     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-016-9832-8     Document Type: Article

References (51)

1. Deckert J et al (2006) Protein composition and electron microscopy structure of affinity-purified human spliceosomal B complexes isolated under physiological conditions. Mol Cell Biol 26:5528–5543
2. Lai MC, Lee YH, Tarn WY (2008) The DEAD-box RNA helicase DDX3 associates with export messenger ribonucleoproteins as well as tip-associated protein and participates in translational control. Mol Biol Cell 19:3847–3858
3. Kasim V et al (2013) Determination of the role of DDX3 a factor involved in mammalian RNAi pathway using an shRNA-expression library. PloS One 8:e59445
4. Lee CS et al (2008) Human DDX3 functions in translation and interacts with the translation initiation factor eIF3. Nucleic Acids Res 36:4708–4718
5. Bol GM et al (2015) Targeting DDX3 with a small molecule inhibitor for lung cancer therapy. EMBO Mol Med 7:648–669
6. Heerma van Voss MR et al (2015) Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer. Oncotarget 6:28312–28326
7. Li Y et al (2006) Inducible resistance of tumor cells to tumor necrosis factor-related apoptosis-inducing ligand receptor 2-mediated apoptosis by generation of a blockade at the death domain function. Cancer Res 66:8520–8528
8. Sun M et al (2008) Identification of an antiapoptotic protein complex at death receptors. Cell Death Differ 15:1887–1900
9. Shih JW et al (2012) Critical roles of RNA helicase DDX3 and its interactions with eIF4E/PABP1 in stress granule assembly and stress response. Biochem J 441:119–129
10. Botlagunta M et al (2008) Oncogenic role of DDX3 in breast cancer biogenesis. Oncogene 27:3912–3922
11. Nozaki K et al (2014) DDX3X induces primary EGFR-TKI resistance based on intratumor heterogeneity in lung cancer cells harboring EGFR-activating mutations. PLoS One 9:e111019
12. Sun M et al (2011) The role of DDX3 in regulating Snail. Biochim Biophys Acta 1813:438–47
13. Hagerstrand D et al (2013) Systematic interrogation of 3q26 identifies TLOC1 and SKIL as cancer drivers. Cancer Discov 3:1044–1057
14. Chen HH et al (2015) DDX3 modulates cell adhesion and motility and cancer cell metastasis via Rac1-mediated signaling pathway. Oncogene 34:2790–2800
15. Xie M et al (2015) NZ51, a ring-expanded nucleoside analog, inhibits motility and viability of breast cancer cells by targeting the RNA helicase DDX3. Oncotarget 6:29901–29913
16. Xie M et al (2016) RK-33 radiosensitizes prostate cancer cells by blocking the RNA helicase DDX3. Cancer Res. doi:10.1158/0008-5472.CAN-16-0440
17. Wilky BA et al (2016) RNA helicase DDX3: a novel therapeutic target in Ewing sarcoma. Oncogene 35:2574–2583
18. Zeichner SB et al (2015) Survival of patients with de-novo metastatic breast cancer: analysis of data from a large breast cancer-specific private practice, a university-based cancer center and review of the literature. Breast Cancer Res Treat 153:617–624
19. Steeg PS (2016) Targeting metastasis. Nat Rev Cancer 16:201–218
20. Society AC (2015) Cancer facts & figures. American Cancer Society, Atlanta
21. Hoefnagel LD et al (2010) Receptor conversion in distant breast cancer metastases. Breast cancer res 12: R75
22. Jiwa LS et al (2014) Upregulation of Claudin-4, CAIX and GLUT-1 in distant breast cancer metastases. BMC Cancer 14:864
23. The Medical Research Involving Human Subjects Act, 1998 [In Dutch: Wet medisch-wetenschappelijk onderzoek met mensen, WMO]. Burgerlijk Wetboek.
24. van Diest PJ (2002) No consent should be needed for using leftover body material for scientific purposes. BMJ 325:648–651
25. Angus AG et al (2010) Requirement of cellular DDX3 for hepatitis C virus replication is unrelated to its interaction with the viral core protein. J Gen Virol 91:122–132
26. Yedavalli VS et al (2004) Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 119:381–392
27. Budczies J et al (2012) Cutoff finder: a comprehensive and straightforward web application enabling rapid biomarker cutoff optimization. PloS One 7:e51862
28. Wu DW et al (2014) DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer. Oncogene 33:1515–1526
29. Chang PC et al (2006) DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control. Oncogene 25:1991–2003
30. Cet al (2015) DDX3 has divergent roles in head and neck squamous cell carcinomas in smoking versus non-smoking patients. Oral Dis 21:270–271
31. Pugh TJ et al (2012) Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488:106–110
32. Seiwert TY et al (2015) Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas. Clin Cancer Res 21:632–641
33. Ojha J et al (2015) Identification of recurrent truncated DDX3X mutations in chronic lymphocytic leukaemia. Br J Haematol 169:445–448
34. Wang L et al (2011) SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 365:2497–2506
35. Nik-Zainal S et al (2016) Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534:47–54
36. Topisirovic I et al (2009) Molecular dissection of the eukaryotic initiation factor 4E (eIF4E) export-competent RNP. EMBO J 28:1087–1098
37. Andersen JS et al (2002) Directed proteomic analysis of the human nucleolus. Curr Biol 12:1–11
38. Anders CK et al (2011) The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases. Cancer 117:1602–1611
39. Nguyen DX et al (2009) WNT/TCF signaling through LEF1 and HOXB9 mediates lung adenocarcinoma metastasis. Cell 138:51–62
40. Pukrop T et al (2010) Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way. Glia 58:1477–1489
41. Cruciat CM et al (2013) RNA helicase DDX3 is a regulatory subunit of casein kinase 1 in Wnt-beta-catenin signaling. Science 339:1436–1441
42. McMullin RP et al (2014) A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity. Breast Cancer Res 16:R25
43. Woditschka S et al (2014) DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancer. J Natl Cancer Inst 106:dju145
44. Berghoff AS et al (2015) Differential role of angiogenesis and tumour cell proliferation in brain metastases according to primary tumour type: analysis of 639 cases. Neuropathol Appl Neurobiol 41:e41–e55
45. Bol GM et al (2013) Expression of the RNA helicase DDX3 and the hypoxia response in breast cancer. PloS One 8:e63548
46. Dupuy F et al (2015) PDK1-dependent metabolic reprogramming dictates metastatic potential in breast cancer. Cell Metab 22:577–589
47. Chen EI et al (2007) Adaptation of energy metabolism in breast cancer brain metastases. Cancer Res 67:1472–1486
48. Palmieri D et al (2009) Analyses of resected human brain metastases of breast cancer reveal the association between up-regulation of hexokinase 2 and poor prognosis. Mol Cancer Res 7:1438–1445
49. Heitz F et al (2009) Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases. Eur J Cancer 45:2792–2798
50. Bol GM, Xie M, Raman V (2015) DDX3, a potential target for cancer treatment. Mol Cancer 14:188
51. Steeg PS, Camphausen KA, Smith QR (2011) Brain metastases as preventive and therapeutic targets. Nat Rev Cancer 11:352–363